Renalys Pharma

About:

Renalys Pharma is a biopharmaceutical firm that develops therapeutics to improve the lives of patients facing renal issues.

Website: https://renalys.com

Top Investors: SR One, Nippon Venture Capital, Sumitomo Mitsui Trust Bank, Catalys Pacific, Japan Post Investment

Description:

Renalys Pharma is a private, late-stage clinical biopharmaceutical firm in Japan dedicated on developing new therapies that address unmet needs in the management of renal illness in Japanese and Asian patients.

Total Funding Amount:

6B JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tokyo, Tokyo, Japan

Founded Date:

2023-01-01

Founders:

BT Slingsby, Takeshi Takahashi

Number of Employees:

11-50

Last Funding Date:

2024-07-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai